{
    "2020-03-03": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Top Analyst Reports for Merck, Novartis & Mondelez",
                "features": {
                    "keywords": [
                        "Merck",
                        "Novartis",
                        "Mondelez",
                        "analyst reports"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "consumer goods"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "European stocks close higher, as pharma sector rallies but banks left behind",
                "features": {
                    "keywords": [
                        "European stocks",
                        "pharma sector",
                        "banks"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-20",
                "original_text": "Alcon Finance Corporation -- Moody's announces completion of a periodic review of ratings of Alcon Inc.",
                "features": {
                    "keywords": [
                        "Alcon",
                        "Moody's",
                        "ratings"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-06-12",
                "original_text": "Roche's Esbriet Gets FDA Breakthrough Tag for New Indication",
                "features": {
                    "keywords": [
                        "Roche",
                        "Esbriet",
                        "FDA",
                        "breakthrough"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-05",
                "original_text": "The Daily Biotech Pulse: GenMark Diagnostics Ships COVID-19 Test Kits, Karyopharm To Offer Shares, And More",
                "features": {
                    "keywords": [
                        "GenMark Diagnostics",
                        "COVID-19",
                        "Karyopharm",
                        "shares"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-18",
                "original_text": "Novartis generics unit admits to fixing drug prices",
                "features": {
                    "keywords": [
                        "Novartis",
                        "generics",
                        "drug prices",
                        "admits"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-09-25",
                "original_text": "Novartis' Sandoz To Pay $195M For Price-Fixing",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Sandoz",
                        "price-fixing",
                        "penalty"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-10-10",
                "original_text": "Drug maker Sandoz to pay $195 million penalty in antitrust case",
                "features": {
                    "keywords": [
                        "Sandoz",
                        "antitrust",
                        "penalty"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}